Initiating Phase I/II clinical trials on patients at risk or already infected

Projects should leverage clinical trials expertise to rapidly intiate clinical trials for prevention and/or treatment for COVID-19

Amount
Not limited
Agency or Funder
National Heart, Lung, and Blood Institute
Eligibility (if available)

Must already possess an NHLBI Phase I-III clinical trial award

Foreign participation? (where known)
No
Keywords
Clinical Studies
Prevention
Therapeutics
Country
US
Link(s) to announcement or call
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-782.html
Date of announcement
Date application deadline
View more opportunities from US View more opportunities